Abstract

  Kawasaki disease is an acute febrile illness of early childhood; less than one per cent of cases are older than ten years. We report here a 13 and half years old male patient presenting with high grade fever, asthenia, myalgia, arthralgia and liver involvement followed by non-exudative conjunctivitis, skin rash on extremities plus desquamation; viral PCR panel was positive for human coronavirus HCOV-OC 43; Blood test showed elevated inflammatory markers, cholestasis and increased platelet count. After elimination of viral, bacterial and autoimmune causes we started IVIG for incomplete Kawasaki disease with good response in 24 hrs.

  Kawasaki disease is uncommon in adolescent patients, so diagnosis could be delayed increasing the risk of coronary artery anevrysm; also the cause is unknown, it may be caused by some viral illness and in our case it turn to be the human coronavirus HCOV-OC 43; liver involvement can be present in Kawasaki disease and it’s due to hepatobiliary dysfunction.

  Adolescent with Kawasaki disease may have atypical presentation, the diagnosis can be difficult; we suggest to have a high index of suspicion in evaluating adolescent patients with high grade fever of unknown origin regarding the possibility of having atypical Kawasaki and the possible coronary artery disease.

Keywords: Kawasaki Disease; Human Coronavirus OC43; Liver Involvement; Adolescent Patient; Vasculitis

References

1. Stockheim JA., et al. “Kawasaki disease in older children and adolescents”. Journal of Pediatrics 137 (2000): 250-252.
2. Momenah T., et al. “Kawasaki disease in the older child”. Pediatrics 102 (1998): e7.
3. Son MBF and Newburger JW. “Kawasaki disease”. Pediatric Review 39.2 (2018): 78-90.
4. American Academy of Pediatrics. Red book: report of the Committee on Infectious Diseases, 25th ed., Elk Grove Village, IL American Academy of Pediatrics (2000).
5. Rosenfeld EA., et al. “Kawasaki disease in infants less than one year of age”. Journal of Pediatrics 126 (1995): 524-529.
6. Yanagawa H., et al. “Nationwide epidemic of Kawasaki disease in Japan during winter of 1985-86”. Lancet 2 (1986): 1138-1139.
7. Bell DM., et al. “Kawasaki syndrome: description of two outbreaks in the United States”. The New England Journal of Medicine 304 (1981): 568-575.
8. Ksiazek TG., et al. “A novel coronavirus associated with severe acute respiratory syndrome”. The New England Journal of Medicine 348 (2003): 1953-1966.
9. Drosten C., et al. “Identification of a novel coronavirus in patients with severe acute respiratory syndrome”. The New England Journal of Medicine 348 (2003): 1967-1976.
10. Han RK., et al. “Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease”. Archives of Pediatrics and Adolescent Medicine 154 (2000): 694-699.
11. Chau TN., et al. “SARS‐associated viral hepatitis caused by a novel coronavirus: report of three cases”. Hepatology 39.2 (2004): 302-310.‏

Citation

Citation: Lina Mortada., et al. “Atypical Kawasaki Disease in Adolescent Male with Liver Involvement Following Human Coronavirus OC43 Infection”. Acta Scientific Paediatrics 3.3 (2020): 53-55.

Copyright

Copyright: © 2020 Lina Mortada., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.